umifenovir has been researched along with erlotinib hydrochloride in 1 studies
Studies (umifenovir) | Trials (umifenovir) | Recent Studies (post-2010) (umifenovir) | Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) |
---|---|---|---|---|---|
234 | 23 | 172 | 4,353 | 786 | 3,033 |
Protein | Taxonomy | umifenovir (IC50) | erlotinib hydrochloride (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 0.1683 | |
Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 1.705 | |
Serine/threonine-protein kinase B-raf | Mus musculus (house mouse) | 0.04 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, YF; Fang, ZZ; Ge, GB; Hu, CM; Song, JH; Zhao, DW; Zhu, LL | 1 |
1 other study(ies) available for umifenovir and erlotinib hydrochloride
Article | Year |
---|---|
Glucuronidation of the broad-spectrum antiviral drug arbidol by UGT isoforms.
Topics: Androsterone; Antiviral Agents; Enzyme Inhibitors; Erlotinib Hydrochloride; Glucuronides; Glucuronosyltransferase; Humans; Indoles; Isoenzymes; Kinetics; Mefenamic Acid; Metabolic Detoxication, Phase II; Microsomes, Liver; Quinazolines; Recombinant Proteins; Tandem Mass Spectrometry; UDP-Glucuronosyltransferase 1A9; Uridine Diphosphate Glucuronic Acid | 2013 |